GeoVax Labs, Inc. Price Today
GeoVax Labs, Inc.
GOVX
Healthcare
$15.01M
💰
Market Cap
0
💸
Price to Earnings
$-0.7
🎉
EPS
+0
🌳
ESG
Consensus Recommendations
Buy Consensus
Buy |
8 |
Strong Buy |
2 |
Hold |
1 |
Sell |
0 |
Strong Sell |
0 |
GOVX Price Forecast Target
0.6 👉 8.0 +1309%
GOVX EPS Forecast
-0.7 👉 -0.7 +-1%
Financials
Profit Margin
0 %
Revenue Growth
0 %
Dividend
$ 0
Held Percent
1.2% - Insiders
6.1% - Institutions
92.7% - Public
Major Fund Holders
-
💰 Vanguard Group Inc $486,105.0
-
💰 Blackrock Inc. $274,940.0
-
💰 Geode Capital Management, LLC $114,878.0
-
💰 State Street Corporation $65,131.0
-
💰 Morgan Stanley $33,381.0
Stock Ideas
Michael Platt Portfolio
Michael Platt is the founder and CEO of BlueCrest Capital Management, a global macro hedge fund with a focus on systematic trading strategies. Prior to starting BlueCrest, Platt worked as a portfolio manager and trader, gaining experience across glo…
David Tepper Portfolio
David Tepper is a renowned billionaire investor, widely known for his incredible success during the 2009 financial crisis where he made a staggering $4 billion. His financial prowess has earned him the distinction of being the 258th richest individ…
Andreas Halvorsen Portfolio
Andreas Halvorsen is a Norwegian billionaire investor, hedge fund manager, and the founder of Viking Global Investors, a large hedge fund with over $50 billion in assets under management. He is known for his long-term, value-oriented investment appr…
Paul Tudor Jones Portfolio
Paul Tudor Jones is a pioneer in macro trading and founder of Tudor Investment Corporation, one of the earliest pioneering hedge funds. With over 40 years of experience investing across global markets, Jones strategically allocates capital based on …📮FAQ
Some Frequently Asked Questions.
The GeoVax Labs, Inc. industry is Biotechnology
The GeoVax Labs, Inc. sector is Healthcare
The GeoVax Labs, Inc. forecasted predicted Price to Earnings PE ratio is -0.8
The GeoVax Labs, Inc. Price to Earnings PE ratio is 0
The Market Capitalization of GeoVax Labs, Inc. is $15.01M
There are total of 26105170 float shares with 6.1% held by Institutions and 1.2% held by insiders
The MGeoVax Labs, Inc. forecasted Earnings per Share EPS is $-0.7
The GeoVax Labs, Inc. Earnings per Share EPS is -0.7
The GeoVax Labs, Inc. company has $0 gross profits with 0 profit margins
The GeoVax Labs, Inc. Earnings Growth is 0% with 0% quarterly earnings growth
The GeoVax Labs, Inc. Revenue is $0 with 0 revenue growth
The price target for GeoVax Labs, Inc. stock is $8.0 for the high target and $3.0 for the low target
The consensus analyst recommendations for GeoVax Labs, Inc. is Buy, however the decision to buy or sell the stock should be entirely yours, as you are earning your own money and hence responsible on how to allocate and spend them.
The consensus analyst recommendations for GeoVax Labs, Inc. is Buy, with the following breakdown:
- Buy: 8
- Strong Buy: 2
- Hold: 1
- Sell: 0
- Strong Sell: 0
The Beta of GeoVax Labs, Inc. is 2.9
The dividend of GeoVax Labs, Inc. is $0
The dividend yield of GeoVax Labs, Inc. is 0%
The biggest institutional and mutual fund holders of GeoVax Labs, Inc. stock are
- Vanguard Group Inc
- Blackrock Inc.
- Geode Capital Management, LLC
- State Street Corporation
The GeoVax Labs, Inc. ESG Score is 0, with the following breakdown:
- E: 0
- S: 0
- G: 0